Xing-Wang Chen1, Fang-Yuan Han2, Gang Su1, Le Pan1, Shan-Jun Cai3. 1. Department of Ophthalmology, Guizhou Eye Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China. 2. Department of Ophthalmology, the Third Affiliated Hospital of Zunyi Medical University (the First People's Hospital of Zunyi), Zunyi 563000, Guizhou Province, China. 3. Zunyi Medical University, Zunyi 563000, Guizhou Province, China.
Abstract
AIM: To observe choroidal thickness changes in the choroidal hyperpermeability area (CHA) in patients with central serous chorioretinopathy (CSC) after photodynamic therapy (PDT) using indocyanine green angiography (ICGA) combined with optical coherence tomography (OCT). METHODS: This was a cohort study of 17 eyes (17 patients) with CSC. In all patients, the range of CHA was determined by ICGA. The patients were divided into two groups based on CHA covered the fovea (group A) or not (group B). All patients received half-dose verteporfin PDT over CHA in ICGA. Choroidal thickness was measured by OCT before, 1, and 3mo after treatment. The choroidal thickness values of the fovea and CHAs were obtained for each measurement. Secondary outcomes were changes in the best-corrected visual acuity (BCVA) and amount of subretinal fluid (SRF). RESULTS: The differences in center choroidal thickness at baseline and at 1 and 3mo post-PDT were statistically significant in group A and all patients (both P<0.001). There was no significant difference in group B (P=0.059). The differences of thickness of CHA and BCVA at baseline and 1 and 3mo post-PDT were statistically significant in group A, group B, and all patients (all P<0.01). All patients showed complete SRF absorption at 3mo post-PDT. CONCLUSION: Center choroidal thickness does not accurately reflect changes in CHA of patients whose CHA does not covered the fovea center. Using CHA as the observation target can make up for this limitation, expand the scope of application, and reduce bias. International Journal of Ophthalmology Press.
AIM: To observe choroidal thickness changes in the choroidal hyperpermeability area (CHA) in patients with central serous chorioretinopathy (CSC) after photodynamic therapy (PDT) using indocyanine green angiography (ICGA) combined with optical coherence tomography (OCT). METHODS: This was a cohort study of 17 eyes (17 patients) with CSC. In all patients, the range of CHA was determined by ICGA. The patients were divided into two groups based on CHA covered the fovea (group A) or not (group B). All patients received half-dose verteporfin PDT over CHA in ICGA. Choroidal thickness was measured by OCT before, 1, and 3mo after treatment. The choroidal thickness values of the fovea and CHAs were obtained for each measurement. Secondary outcomes were changes in the best-corrected visual acuity (BCVA) and amount of subretinal fluid (SRF). RESULTS: The differences in center choroidal thickness at baseline and at 1 and 3mo post-PDT were statistically significant in group A and all patients (both P<0.001). There was no significant difference in group B (P=0.059). The differences of thickness of CHA and BCVA at baseline and 1 and 3mo post-PDT were statistically significant in group A, group B, and all patients (all P<0.01). All patients showed complete SRF absorption at 3mo post-PDT. CONCLUSION: Center choroidal thickness does not accurately reflect changes in CHA of patients whose CHA does not covered the fovea center. Using CHA as the observation target can make up for this limitation, expand the scope of application, and reduce bias. International Journal of Ophthalmology Press.
Entities:
Keywords:
central serous chorioretinopathy; choroidal hyperpermeability; choroidal thickness; indocyanine green angiography; optical coherence tomography
Authors: A Rabiolo; I Zucchiatti; A Marchese; G Baldin; R Sacconi; D Montorio; M V Cicinelli; L Querques; F Bandello; G Querques Journal: Eye (Lond) Date: 2017-12-21 Impact factor: 3.775
Authors: Pierluigi Iacono; Maurizio Battaglia Parodi; Bruno Falcomatà; Francesco Bandello Journal: Ophthalmic Res Date: 2015-12-01 Impact factor: 2.892
Authors: Cynthia A Carvalho-Recchia; Lawrence A Yannuzzi; Silvana Negrão; Richard F Spaide; K Bailey Freund; Hanna Rodriguez-Coleman; Marcio Lenharo; Tomohiro Iida Journal: Ophthalmology Date: 2002-10 Impact factor: 12.079
Authors: Alice Verticchio Vercellin; Alon Harris; Ari M Stoner; Francesco Oddone; Kristen Ann Mendoza; Brent Siesky Journal: J Clin Med Date: 2022-02-23 Impact factor: 4.241